Alembic Pharmaceuticals Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 | Sep-26 |
|---|---|---|---|---|---|---|---|---|
| 1,693 | 1,770 | 1,711 | 1,910 | 1,876 | 1,848 | 2,150 | 2,603 | |
| 10 | 14 | 7 | 7 | 16 | 26 | 15 | 15 | |
| 1,525 | 1,591 | 1,527 | 1,695 | 1,686 | 1,731 | 1,943 | 2,179 | |
| 447 | 426 | 431 | 463 | 449 | 404 | 517 | 600 | |
| 120 | 93 | 109 | 127 | 143 | 130 | 121 | 177 | |
| −128 | 12 | −133 | −74 | −63 | −2 | −18 | −91 | |
| 398 | 394 | 423 | 438 | 433 | 439 | 474 | 504 | |
| 22 | 25 | 24 | 24 | 23 | 23 | 28 | 38 | |
| 70 | 69 | 74 | 76 | 80 | 89 | 98 | 101 | |
| 595 | 574 | 599 | 641 | 621 | 649 | 724 | 851 | |
| 270 | 286 | 288 | 323 | 267 | 229 | 347 | 578 | |
| 200 | 217 | 214 | 247 | 187 | 140 | 249 | 478 | |
| — | — | — | — | −42 | −25 | — | — | |
| 177 | 193 | 191 | 222 | 163 | 118 | 221 | 439 | |
| 40 | 35 | 36 | 40 | 30 | −83 | 50 | 104 | |
| 138 | 157 | 154 | 184 | 132 | 202 | 172 | 334 | |
| Financial ratios | ||||||||
| 15.93% | 16.17% | 16.83% | 16.89% | 14.22% | 12.38% | 16.13% | 22.22% | |
| 8.13% | 8.85% | 8.98% | 9.62% | 7.03% | 10.91% | 8.02% | 12.83% | |
| 7.01 | 7.98 | 7.85 | 9.40 | 6.76 | 10.31 | 8.80 | 17.05 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.